申请人:Sage Therapeutics, Inc.
公开号:US20220220150A1
公开(公告)日:2022-07-14
Described herein are neuroactive steroids of the Formula (I):
or a pharmaceutically acceptable salt thereof, wherein
, A, R
1
, R
2
, R
3a
, R
4a
, R
4b
, R
5
, R
7a
, and R
7b
are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.